drugset / Trial / NCT05587699
The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A
RandomizedParallel-groupOpen-labelTreatment
Summary
A study to evaluate the pharmacokinetics, pharmacodynamics, and safety of CKD-843 A in male subjects.
Timeline
- Start
- 2022-11-15
- Primary completion
- 2023-09-15
- Completion
- 2023-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-843 A | Unknown | 45 mg | — |
| Subject | CKD-843 A | Unknown | 55 mg | — |
| Comparator | CKD-843-R | Unknown | 0.5 mg | — |